Angelini Ventures joins VectorY’s €74.5M financing to advance new therapies for ALS and other neurodegenerative diseases 11/11/2026 Category: INVESTMENTS
Nouscom raises €120M to take cancer interception into a global registration-enabling trial 10/19/2026 Category:
MMI Closes $125 Million Series D to Scale Robotic Microsurgery Globally 10/9/2026 Category: PORTFOLIO NEWS, INVESTMENTS
Angelini Ventures and EIB back RougeTx's $58M Series A, advancing a first-in-class treatment for a rare bleeding disorder 10/6/2026 Category: INVESTMENTS
Portfolio Company Freya Biosciences Recognized Among Fierce Biotech's Fierce 15 10/5/2026 Category: PORTFOLIO NEWS
Angelini Ventures